The role of vitamin D, obesity and physical exercise in regulation of glycemia in Type 2 Diabetes Mellitus patients

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 10, Issue 4, 2016, Pages 198-204

  Bener, Abdulbari ^a,b   Al Hamaq, Abdulla O A A ^c   Kurtulus, Eda Merve ^a   Abdullatef, Waleed K ^d   Zirie, Mahmoud ^e  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c QATAR FOUNDATION   (Qatar)

^d HAMAD MEDICAL CORPORATION   (Qatar)

^e HAMAD GENERAL HOSPITAL   (Qatar)

Author keywords

Diabetes mellitus; Epidemiology; Lipid profile; Physical exercise; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BILIRUBIN; CALCIUM; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL; URIC ACID; VITAMIN D;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMORBIDITY; CONSANGUINITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; EDUCATIONAL STATUS; ETHNICITY; EXERCISE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HYPERTENSION; INCOME; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; OCCUPATION; PRIORITY JOURNAL; QATAR; SMOKING; SPORT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; COMPARATIVE STUDY;

EID: 84994798378     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2016.06.007     Document Type: Article

References (41)

1. [1] Wild, S., Roglic, G., Green, A., Sicree, R., King, H., Global prevalence of diabetes −estimates for the year 2000 and projection for 2030. Diabetes Care 27 (2004), 1047–1053.
2. [2] World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation WHOINCDINCS/99.2, 1999, World Health Organization, Geneva.
3. [3] International Diabetes Federation, IDF Diabetes Atlas. sixth edition, 2014, IDF, 166 Chaussee de La Hulpe B-1170, Brussels, Belgium.
4. [4] Shaw, J.E., Sicree, R.A., Zimmet, P.Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:1 (2010), 4–14.
5. [5] Bener, A., Zirie, M., Al-Rikabi, R., Genetics: obesity and environmental risk factors associated with Type 2 diabetes. Croat Med J 46:2 (2005), 302–307.
6. [6] Hu, F.B., Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34:6 (2011), 1249–1257.
7. [7] Bener, A., Kim, E., Mutlu, F., Eliyan, A., Delghan, H., Nofal, E., et al. Burden of Diabetes Mellitus Attributable to demographic levels in Qatar: an emerging public health problem. Diabetes Metab Syndr 8:4 (2014), 216–220.
8. [8] Bener, A., Zirie, M., Janahi, I.M., Al Hamaq, A.O.A.A., Musallam, M., Wareham, N.J., Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diab Res Clin Pract 84 (2009), 99–106.
9. [9] Bener, A., Zirie, M., Musallam, M., Khader, Y.S., Al-Hamaq, A.O.A.A., Prevalence of metabolic syndrome according to ATP III and IDF criteria: a population based study. Met Syndrome Rel Dis 7 (2009), 221–230.
10. [10] Bener, A., Abdulmalik, M., Al-kazaz, M., Mohammed, A.G., Sanya, R., Buhmaid, S., et al. Medical audit of the quality of diabetes care: is primary care more successful than outpatient clinics of the hospital. J Primary Care Com Health 31 (2012), 42–50.
11. [11] Bener, A., Abdulmalik, M., Al-Kazaz, M., Sanya, R., Buhamaid, S., Al Harthy, M., Does good clinical practice at the primary care improve the outcome care for diabetic Patients? Gender differences. J Primary Care Diab 6 (2012), 285–292.
12. [12] Lim, S., Kim, M., Choi, S., Shin, C., Park, K., Jang, H., et al. Association of vitamin D deficiency with incidence of Type 2 diabetes in high-risk Asian subjects. Am J Clin Nutr 97 (2013), 524–530.
13. [13] Pittas, A., Lau, J., Hu, F., Dawson-Hughes, B., The role of vitamin D and calcium in Type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92 (2007), 2017–2029.
14. [14] Hurskainen, A., Virtanen, J., Tuomainen, T., Nurmi, T., Voutilainen, S., Association of serum 25-hydroxyvitamin D with Type 2 Diabetesand markers of insulin resistance in a general older population in Finland. Diabetes Metab Res Rev 28 (2012), 418–423.
15. [15] Need, A., O'Loughlin, P., Horowitz, M., Nordin, B., Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxford) 62 (2005), 738–741.
16. y2 gene on diabetes and obesity in a highly consanguineous population. Indian J Endocrinol Metab 19:1 (2015), 77–83.
17. [17] Li, Y.X., Zhou, L., Vitamin D deficiency, obesity and diabetes. Cell Mol Biol (Noisy-le-grand) 61:June (3) (2015), 35–38.
18. [18] Kostoglou-Athanassiou, I., Athanassiou, P., Gkountouvas, A., Kaldrymides, P., Vitamin D and glycemic control in diabetes mellitus type 2. Ther Adv Endocrinol Metab 4:4 (2013), 122–128.
19. [19] Cavalier, E., Delanaye, P., Souberbielle, J.C., Radermecker, R.P., Vitamin D and type 2 diabetes mellitus: where do we stand?. Diabetes Metab 37:4 (2011 Sep), 265–272.
20. [20] Mezza, T., Muscogiuri, G., Sorice, G.P., Prioletta, A., Salomone, E., Pontecorvi, A., et al. Vitamin D deficiency:a new risk factor for type 2 diabetes. Ann Nutr Metab 61 (2012), 337–348.
21. [21] Pittas, A., Nelson, J., Mitri, J., Hillmann, W., Garganta, C., Nathan, D., Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care 35 (2012), 565–573.
22. [22] National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report, Circulation (2002) 106:3143–3342.
23. [23] Gagnon, C., Lu, Z.X., Magliano, D.J., Dunstan, D.W., Shaw, J.E., Zimmet, P.Z., et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 97 (2012), 1953–1961.
24. [24] Pittas, A.G., Sun, Q., Manson, J.E., Dawson-Hughes, B., Hu, F.B., Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 33 (2010), 2021–2023.
25. [25] Bener, A., Alsaied, A., Al-Ali, M., Al-Kubaisi, A., Basha, B., Abraham, A., et al. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetol 46 (2009), 183–189.
26. [26] Holick, M., Binkley, N., Bischoff-Ferrari, H., Gordon, C., Hanley, D., Heaney, R., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96 (2011), 1911–1930.
27. [27] World Health Organization, International Society of Hypertension Writing Group: 2003. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens (2003) 21:1983–1992.
28. [28] Erica Stivelman, E., Retnakaran, R., Role of Vitamin D in the pathophysiology and treatment of type 2 diabetes. Curr Diab Rev 8 (2012), 42–47.
29. [29] D'Ambrosio, D., Cippitelli, M., Cocciolo, M.G., Mazzeo, D., Di Lucia, P., Lang, R., et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3 involvement of NF-kB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101 (1998), 252–262.
30. [30] Elkassaby, S., Harrison, L.C., Mazzitelli, N., Wentworth, J.M., Colman, P.G., Spelman, T., A randomised controlled trial of high dose vitamin D in recent-onset type 2 diabetes. Diabetes Res Clin Pract 106:3 (2014), 576–582.
31. [31] Bener, A., Al-Laftah, F., Al-Hamaq, A.O.A.A., Daghash, M., Abdullatef, W.K., A study of diabetes complications in an endogamous population: an emerging public health burden. Diabetes Metab Syndr 8:2 (2014), 108–114.
32. [32] Bener, A., Darwish, S., Yousafzai, M.T., Al-Hamaq, A.O.A.A., Nasralla, E.A., Abdul-Ghani, M., Obesity index that better predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio. Obesity, 2013, 10.1155/2013/269038.
33. [33] Bener, A., Darwish, S., Yousafzai, M.T., Al-Hamaq, A.O.A.A., Nasralla, E.A., The potential impact of family history of metabolic syndrome and risk of type 2 diabetes mellitus: in a highly endogamous population. Indian J Endocr Metab 18:2 (2014), 202–209.
34. [34] Bener, A., Yousafzai, M.T., Al-Hamaq, A.O., Familial aggregation of T2DM among arab diabetic population. Int J Diabetes Dev Countries 32:2 (2012), 90–92.
35. [35] Simpson, M., Brady, H., Yin, X., Seifert, J., Barriga, K., Hoffman, M., et al. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 54:11 (2011), 2779–2788.
36. [36] Turpeinen, H., Hermann, R., Vaara, S., Laine, A.P., Simell, O., Knip, M., et al. Vitamin D receptor polymorphisms: no association with type 1 diabetes in the Finnish population. Eur J Endocrinol 149 (2003), 591–596.
37. [37] Go, M.J., Hwang, J.Y., Park, T.J., Kim, Y.J., Oh, J.H., Han, B.G., et al. Genome-wide association study identifies two novel Loci with sex-specific effects for Type 2 Diabetes Mellitus and glycemic traits in a Korean population. Diabetes Metab J 38:5 (2014), 375–387.
38. [38] Saedisomeolia, A., Taheri, E., Djalali, M., Moghadam, A.M., Qorbani, M., Association between serum level of vitamin D and lipid profiles in type 2 diabetic patients in Iran. J Diabetes Metabolic Dis, 13, 2014, 7.
39. [39] Palomer, X., González-Clemente, J.M., Blanco-Vaca, F., Mauricio, D., Role of Vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obesity Metabolism, 2008, 185–197.
40. [40] Compston, J.E., Vedi, S., Ledger, J.E., Webb, A., Gazet, J.C., Pilkington, T.R., Vitamin D status and bone histo morphometry in gross obesity. Am J Clin Nutr 34 (1981), 2359–2363.
41. [41] Thomas, G.N., Scragg, R., Jiang, C.Q., Chan, W., März, W., Pilz, S., Hyperglycaemia and vitamin D: a systematic overview. Cur Diab Rev 8 (2012), 18–31.